Rockefeller Capital Management L.P.
Position in WGS — GeneDx Holdings Corp.
CIK 1739439
NEW YORK, NY
Position in WGS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,377,407
+$4,174,399 QoQ
Shares Held
151,164
+56.5% QoQ
Ownership
0.507%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#38
of 223 holders
Holding Since
Sep 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WGS Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Rockefeller Capital Management L.P. holds $424,737,051 across 30 Diagnostics & Research names. WGS ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
426,025 | $213,591,890 | |
| 2 | DHR |
Danaher Corp /De/
|
330,005 | $62,859,350 | |
| 3 | RDNT |
RadNet, Inc.
|
757,990 | $46,745,242 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
51,299 | $27,005,843 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
11,634 | $14,862,548 | |
| 6 | WGS |
GeneDx Holdings Corp.
This page
|
151,164 | $10,377,407 | |
| 7 | ILMN |
Illumina, Inc.
|
51,929 | $9,130,674 | |
| 8 | A |
Agilent Technologies, Inc.
|
58,592 | $7,782,774 |
All Filings in WGS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,377,407 | 151,164 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,203,008 | 96,590 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $73,092 | 562 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $53,870 | 500 | Shares | Defined | 2025-11-14 | |
| 2021-09-30 | $196,505 | 25,890 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||